solid-phase, reversible dye-terminator sequencing (Illumina Inc)
Illumina Inc is a verified supplier 
90
Structured Review
Illumina Inc
solid-phase, reversible dye-terminator sequencing
Solid Phase, Reversible Dye Terminator Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/solid-phase%2C+reversible+dye-terminator+sequencing/solid+phase++reversible+dye+terminator+sequencing/us12358918-72-23-27
Average 90 stars, based on 1 article reviews
Solid Phase, Reversible Dye Terminator Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/solid-phase%2C+reversible+dye-terminator+sequencing/solid+phase++reversible+dye+terminator+sequencing/us12358918-72-23-27
Average 90 stars, based on 1 article reviews
solid-phase, reversible dye-terminator sequencing - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Next-Generation Sequencing:Article Title: Methods of enriching and determining target nucleotide sequences Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Personalized cancer vaccines Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics), 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics), solid-phase, Article Title: Single-stranded break detection in double-stranded DNA Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Droplet-based single cell genomic DNA sequencing Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx TherapeuticsTM); 454 pyro-sequencing (454 Life Sciences/Roche DiagnosticsTM); solid-phase, reversible dye-terminator sequencing (SolexaTM/IlluminaTM); SOLiDTM technology (Applied BiosystemsTM); Ion semiconductor sequencing (Ion TorrentTM); and DNA nanoball sequencing (Complete GenomicsTM). Article Title: Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Compositions and methods relating to nucleic acid interaction reporters Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include bridge amplication (Illumina's MiniSeq, MiSeq, NextSeq, NovaSeq, and HiSeq); Massively Parallel Signature Sequencing (Lynx Therapeutics/Illumina); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Methods of nucleic acid sample preparation Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature SequencingTM (Lynx Therapeutics); 454 Pyro-SequencingTM (454 Life Sciences/Roche Diagnostics); solid-phase, Sequencing:Article Title: Methods of enriching and determining target nucleotide sequences Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Personalized cancer vaccines Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics), 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics), solid-phase, Article Title: Single-stranded break detection in double-stranded DNA Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Droplet-based single cell genomic DNA sequencing Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx TherapeuticsTM); 454 pyro-sequencing (454 Life Sciences/Roche DiagnosticsTM); solid-phase, reversible dye-terminator sequencing (SolexaTM/IlluminaTM); SOLiDTM technology (Applied BiosystemsTM); Ion semiconductor sequencing (Ion TorrentTM); and DNA nanoball sequencing (Complete GenomicsTM). Article Title: Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Compositions and methods relating to nucleic acid interaction reporters Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include bridge amplication (Illumina's MiniSeq, MiSeq, NextSeq, NovaSeq, and HiSeq); Massively Parallel Signature Sequencing (Lynx Therapeutics/Illumina); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Methods of nucleic acid sample preparation Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature SequencingTM (Lynx Therapeutics); 454 Pyro-SequencingTM (454 Life Sciences/Roche Diagnostics); solid-phase, DNA Sequencing:Article Title: Methods of enriching and determining target nucleotide sequences Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Personalized cancer vaccines Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics), 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics), solid-phase, Article Title: Single-stranded break detection in double-stranded DNA Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Droplet-based single cell genomic DNA sequencing Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx TherapeuticsTM); 454 pyro-sequencing (454 Life Sciences/Roche DiagnosticsTM); solid-phase, reversible dye-terminator sequencing (SolexaTM/IlluminaTM); SOLiDTM technology (Applied BiosystemsTM); Ion semiconductor sequencing (Ion TorrentTM); and DNA nanoball sequencing (Complete GenomicsTM). Article Title: Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics Article Snippet: NGS sequencing platforms include, but are not limited to, the following: Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Compositions and methods relating to nucleic acid interaction reporters Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include bridge amplication (Illumina's MiniSeq, MiSeq, NextSeq, NovaSeq, and HiSeq); Massively Parallel Signature Sequencing (Lynx Therapeutics/Illumina); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Methods of nucleic acid sample preparation Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature Sequencing (Lynx Therapeutics); 454 pyro-sequencing (454 Life Sciences/Roche Diagnostics); solid-phase, Article Title: Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence Article Snippet: Non-limiting examples of next-generation sequencing methods/platforms include Massively Parallel Signature SequencingTM (Lynx Therapeutics); 454 Pyro-SequencingTM (454 Life Sciences/Roche Diagnostics); solid-phase, |